Correlation between LSM1 Expression and Clinical Outcomes in Glioblastoma and Functional Mechanisms

Figure 3

Impact of LSM1 expression on survival outcomes in glioma patients. The analysis of overall survival (a), disease-specific survival (b), and progression-free survival (c) based on LSM1 expression levels in glioma patients was conducted. Kaplan-Meier survival curves are depicted for patients with either high or low LSM1 expression. The consistent results demonstrate that patients with higher LSM1 expression exhibit significantly worse clinical outcomes in terms of overall survival (a), disease-specific survival (b), and progression-free survival (c).

(a)

(b)

(c)